Jon Napitupulu

Semnur Pharmaceuticals has entered a securities purchase agreement to raise $100 million through a private placement of 6.25 million...

Biogen received a Complete Response Letter from the FDA for its supplemental filing seeking a higher-dose regimen of nusinersen...

Santhera reported a 70% year-on-year revenue jump to CHF 24 million for the first half of 2025 as Agamree...

Genfit reported first-half 2025 results and a strategic refocus in liver disease. The company ended June with €107.5 million...

Benitec Biopharma reported full-year 2025 results and advanced its lead program, announcing an independent data safety monitoring board recommendation...

Semnur Pharmaceuticals has closed its business combination with Denali Capital Acquisition Corp, creating a publicly traded entity that will...

Applied Pharmaceutical Innovation has launched the Life Sciences Placement Program in partnership with Mitacs, aiming to place 1,000 paid...

Angelini Pharma has secured an exclusive global option to develop and commercialize SVG105, a preclinical antisense oligonucleotide targeting the...

Achieve Life Sciences reported new peer-reviewed data showing its investigational agent, cytisinicline, significantly improved continuous abstinence rates versus placebo...

Cosmos Health has launched its U.S. operations with the debut of Sky Premium Life Noor Collagen, a marine collagen...